These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 567284)
1. Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester. Scatton B; Worms P Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):271-8. PubMed ID: 567284 [TBL] [Abstract][Full Text] [Related]
2. Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester. Worms P; Scatton B Eur J Pharmacol; 1977 Oct; 45(4):395-6. PubMed ID: 562764 [No Abstract] [Full Text] [Related]
3. Tolerance to increases in striatal acetylcholine concentrations after repeated administration of apomorphine dipivaloyl ester. Scatton B; Worms P J Pharm Pharmacol; 1979 Dec; 31(12):861-3. PubMed ID: 43377 [No Abstract] [Full Text] [Related]
4. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation. Chivers JK; Reavill C; Jenner P; Marsden CD J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027 [TBL] [Abstract][Full Text] [Related]
5. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903 [No Abstract] [Full Text] [Related]
6. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function. Csernansky JG; Glick S; Mellentin J Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924 [TBL] [Abstract][Full Text] [Related]
7. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Nishikawa T; Mataga N; Takashima M; Toru M Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769 [TBL] [Abstract][Full Text] [Related]
8. Two dopamine receptors: supportive evidence with the rat rotational model. Tye NC; Horsman L; Wright FC; Large BT; Pullar IA Eur J Pharmacol; 1977 Sep; 45(1):87-90. PubMed ID: 560970 [TBL] [Abstract][Full Text] [Related]
9. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine. Agut J; Coviella IL; Wurtman RJ Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245 [TBL] [Abstract][Full Text] [Related]
10. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity. De Veaugh-Geiss J; Devanand DP; Carey RJ Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268 [TBL] [Abstract][Full Text] [Related]
11. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats. Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017 [TBL] [Abstract][Full Text] [Related]
12. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats. Kaneno S; Watanabe A; Takahashi R Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109 [TBL] [Abstract][Full Text] [Related]
13. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment. Nomura Y; Komori T; Okuda S; Segawa T Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682 [TBL] [Abstract][Full Text] [Related]
14. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol. Ahtee L; Kaakkola S Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219 [TBL] [Abstract][Full Text] [Related]
15. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat. Nomura Y; Oki K; Segawa T J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Sayers AC; Bürki HR; Ruch W; Asper H Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492 [TBL] [Abstract][Full Text] [Related]
17. Effects of the l isomer of fenfluramine on dopamine mechanisms in rat brain: further studies. Invernizzi R; Bertorelli R; Consolo S; Garattini S; Samanin R Eur J Pharmacol; 1989 May; 164(2):241-8. PubMed ID: 2759175 [TBL] [Abstract][Full Text] [Related]
18. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. Wheeler SC; Roth RH Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650 [TBL] [Abstract][Full Text] [Related]
19. Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat. Deutsch SI; Halperin R; Stanley M; Davis KL Neurochem Res; 1985 Apr; 10(4):491-8. PubMed ID: 2582289 [TBL] [Abstract][Full Text] [Related]
20. The interaction of clonidine with dopamine-dependent behaviour in rodents. Pycock CJ; Jenner PG; Marsden CD Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]